NetScientific plc is an IP commercialisation company that identifies, develops and commercialises research and technologies originating from leading universities, teaching hospitals and research institutes globally, but particularly in the United Kingdom and the United States.
The Group is primarily focused on identifying and developing research and technologies for use in five chronic disease areas within the healthcare diagnostics sector: (a) Cardiovascular; (b) Liver; (c) Cancer; (d) Metabolic; and (e) Digital Health.
Process Engineering May 9, 2013 - Method simplifies fluid flow design.
R&D Magazine May 8, 2013 - Bioengineers simplify fluid flows by removing complex math.
UCLA Newsroom May 7, 2013 - UCLA bioengineers simplify fluid flows by removing complex math.
Scientific/Vortex Publication | Nature Communications May 7, 2013 - Engineering fluid flow using sequenced nicrostructures.
San Francisco, CA April 15, 2013 – Chronic Liver Disease Patients to use WANDA Remote Monitoring System in new Clinical Research Study | UCLA’s Wireless Health Institute and UCSF’s School of Medicine have secured funding for the implementation of a Clinical Research Study to show how to prevent Hospitalizations in Chronic Liver Disease Patients using WANDA’s Evidence-based Wireless Monitoring & Analytics System.
London September 28, 2012 – MOF Technologies Wins Prestigious Annual Prize | NetScientific portfolio company MOF Technologies was recognized as the spin-out company in Northern Ireland with the greatest commercial potential on Thursday evening, winning the 2012 25k Award.
London June 25, 2012 – WANDA Inc. CTO Addresses US Congress | Professor Majid Sarrafzadeh, of the UCLA Wireless Health Institute and Chief Technology Officer of NetScientific portfolio company WANDA Inc., today addressed the US Congress on the subject of “Saving the Healthcare System”.
London May 21, 2012 - NetScientific Scientist Receives Prestigious Award | The CTO of Vortex Diagnostics Inc, a NetScientific portfolio company has received the prestigious Faculty Early Career Development (CAREER) award from the National Science Foundation, for “High-throughput Single-cell Biophysics.”
MEDCITY News: May 2, 2012 | A NetScientific company is developing a mobile mobile cardiac biomarker testing device could detect heart attacks faster
London March 27, 2012 - Vortex Diagnostics Inc. CTO receives Young Investigator award from U.S. Naval Research | Professor Dino Di Carlo, CTO of NetScientific portfolio company Vortex Diagnostics Inc, has received a Young Investigator Program award from the U.S. Office of Naval Research.
London October 13, 2011 - NetScientific Bioengineer Awarded Packard Fellowship for Science and Engineering | The David and Lucile Packard Foundation has named Dino Di Carlo a 2011 recipient of a Packard Fellowship for Science and Engineering.
London July 12, 2011 - Advanced Biosensors Patent Granted | NetScientific is pleased to announce that portfolio company Advanced Biosensors Inc. which specialises in medical diagnostics, has been issued aU.S. Patent, Number 7,975,547, entitled “Method and Apparatus for Interfacial Sensing”.
London (July 5, 2011) - Vortex Diagnostics CTO Demonstrates Record-Breaking Breast Cancer Cell Detection | The CTO of Vortex Diagnostics Inc, a NetScientific portfolio company has demonstrated real-time identification of rare breast cancer cells in blood with a record low false-positive rate of one cell in a million.early detection of cancer and for monitoring the efficiency of drug and radiation therapy.
London June 20, 2011 | NetScientific announces today that it has appointed Professor Paul Freemont, a pioneer in the emerging field of synthetic biology, to its Scientific Advisory Board.
UCLA Health and Medicine Newsroom: January 10, 2011 | UCLA Wireless Health Institute (WHI)
New York October 7, 2010 | Advanced BioSensors, Inc., a subsidiary of NetScientific America, Inc., has received a further tranche of its $5 million Series A financing round.